Chronic Malignancies Working Party (CMWP)
Study type:
Study number:
42206635
Type of treatment:
Diseases:
Multiple Myeloma (MM) or other Plasma Cell Disorder (PCD)
Short title:
Primary objective:
Key inclusion criteria:
>18 years old; MM; conditioning with melphalan
Country:
Principal investigator:
Mathias Klammer
EBMT Study coordinator:
Erica Knödler